System Maintenance Notice

Please note that maintenance work is scheduled between 4 AM and 5 AM - CET. During this time, you may experience reduced performance. Thanks for your patience.

Juliette Mazereeuw-Hautier

Dermatology — Centre Hospitalier Universitaire de Toulouse, France

LeadR Profile

Juliette Mazereeuw-Hautier Centre Hospitalier Universitaire de Toulouse France
1 370 ScienceLeadR Reputation 1370

Unlock

Register Login
Network Map

Dermatology

Subspecialties: Genetics - Pediatrics - Infectiology

Full career – Last 3 years

Main Topics

Publications and Clinical Studies

Publications – Clinical Studies

Organizations

Source: Pubmed

INSERM

Publications Synthesis

Source: Pubmed

Number : 416

Citations

Citations: 8 699 1st author: 53 Last author: 98 Unique author: 12

Main journals

Ann Dermatol Venereol 164
Br J Dermatol 55
J Eur Acad Dermatol Venereol 25
Acta Derm Venereol 21
Annales de dermatologie et de vénéréologie, FMC 12

Best Journals

N Engl J Med 2
Nat Med 2
Nat Rev Dis Primers 1

Breakdown by type

Latest Publications

5 most recent indexed articles

Source: Pubmed

Title Journal Year Citations
Ophthalmological Abnormalities in syndromic or non-syndromic Epidermal Differentiation Disorders: a cross-sectional study.
cross-sectional studies, syphilis		Br J Dermatol20260
Social Media Listening in Congenital Ichthyosis: Quantitative and Qualitative Findings.
quality of life, social media, ichthyosis		JMIR Form Res20260
Reconsidering Efficacy and Safety: A Critical Appraisal of Repurposing Anti-inflammatory Targeted Drugs in Darier disease.
sexually transmitted diseases, safety, pharmaceutical preparations, darier disease, dermatology		Acta Derm Venereol20260
Higher Doses of Oral Propranolol for Resistant Infantile Haemangio-mas.
sexually transmitted diseases, propranolol, wounds and injuries, dermatology		Acta Derm Venereol20260
Author Correction: Mutations in ACTRT1 and its enhancer RNA elements lead to aberrant activation of Hedgehog signaling in inherited and sporadic basal cell carcinomas.
cells, molecular biology, enhancer elements, genetic, mutation, carcinoma, basal cell, rna		Nat Med Top journal20250

Clinical Studies 19

Source: ClinicalTrials

Synthesis

Principal Investigator: 9

By phase:

N/A 9
Phase 2 7
Phase 2/Phase 3 3

By status:

Recruiting 9
Completed 8
Unknown 2

By type:

Interventional 16
Observational 3

By Monocentric/Multicentric:

monocentric 5
multicentric2to4 6
multicentric5to9 3
multicentricup10 5

Main Topics

Skin and Connective Tissue Diseases 14
Congenital, Hereditary, and Neonatal Diseases and Abnormalities 13
Cardiovascular Diseases 3
Immune System Diseases 2

Ongoing Clinical Trials

5 ongoing trials started since 2021, where this expert is an investigator

Source: ClinicalTrials

Study Phase Status Start
A Study of Zasocitinib in Adults With Nonsegmental Vitiligo
NCT07108283 — skin, safety, pharmaceutical preparations, vitiligo, drug therapy, capsules, immune system, therapeutics		Phase 2Recruiting2025
A Study to Assess the Incidence of Skin Cancers in Patients With Epidermolysis Bullosa Receiving Filsuvez
NCT06423573 — skin, epidermolysis bullosa dystrophica, incidence, epidermolysis bullosa, junctional, epidermolysis bullosa, therapeutics		N/ARecruiting2024
Characterization of the Cytokine Profile and the Microbiome in Darier s Disease
NCT06614777 — cytokines, skin, genes, blood, biopsy, aged, darier disease, pruritus, therapeutics, bacteria, microbiota, plasma		N/ARecruiting2024
A 20 Week Study Assessing the Efficacy of Apremilast in Patients with EB Simplex Generalized
NCT06509984 — safety, epidermolysis bullosa simplex, epidermolysis bullosa, therapeutics, child		Phase 2Recruiting2024
Efficacy and Tolerance of the Association of ANIFROLUMAB (300mg) IV Every Four Weeks and Phototherapy Versus Phototherapy in Adults With Progressive Vitiligo
NCT05917561 — vitiligo, phototherapy		Phase 2Recruiting2023

LeadR Networks

Main global connection map

Source: Pubmed Source: ClinicalTrials